• April 1-3, 2025 – Van Lanschot Kempen Conferences, Amsterdam
Categorie
2025
MaaT Pharma Completes a Capital Increase of €13 Million with Historical Shareholders and Announces 2024 Annual Results Positive results from…
March 27, 2025
To read article, click here
March 20, 2025
MaaT Pharma Announces Positive Outcomes from Final DSMB Meeting for Pivotal Phase 3 Clinical Trial Evaluating MaaT013 in Acute Graft-versus-Host…
March 18, 2025
MaaT Pharma Receives Positive Opinion from EMA Pediatric Committee on the Pediatric Investigation Plan for MaaT013 Positive EMA Pediatric Committee…
March 11, 2025
To see the interview click here
February 24, 2025
To see the interview click here
February 18, 2025
• March 17-19, 2025 – BIO-Europe Spring, Milan, Italy
February 11, 2025
• March 18-19, 2025 – Microbiome Times Partnering Forum
February 11, 2025
To see the interview click here
January 27, 2025
We are a clinical-stage microbiome therapeutics company aiming to improve survival in cancer.
Ressources
Contact
Nous sommes une société au stade clinique, spécialisée dans les thérapies issues du microbiote dédiées aux patients atteints de cancer.
Contact
Nous sommes une société au stade clinique, spécialisée dans les thérapies issues du microbiote dédiées aux patients atteints de cancer.